Elon Musk's Neuralink is reportedly in talks with Barrow Neurological Institute to collaborate on clinical trials for treating conditions like paralysis and blindness through brain implants.

The partnership might lead to further implant research conducted at the institute, which has extensive experience in the field.

While previous reports suggest that Neuralink was rejected by the FDA for human trials, the company is working to address the safety concerns.

With a goal of making brain implants as common as LASIK eye surgery, Elon Musk remains optimistic about Neuralink's potential for success.